West Pharmaceutical Services INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
West Pharmaceutical Services' 2024 10-K filing reveals a slight decrease in net sales and operating profit, alongside strategic investments in manufacturing capacity and share repurchases.
NYSE
West Pharmaceutical Services, Inc. files its annual 10-K report and updates its non-qualified deferred compensation plan for designated employees, effective January 1, 2024.